Use of Add-on Treatment to Metformin Monotherapy for Patients with Type 2 Diabetes and Suboptimal Glycemic Control: A U.S. Database Study

BACKGROUND: The American Diabetes Association (ADA) recommends metformin to treat individuals diagnosed with type 2 diabetes and recommends that hemoglobin A1c (HbA1c) be maintained below or around 7%. If the HbA1c target is not achieved or maintained by metformin monotherapy at maximal tolerated do...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Shengsheng, Schwab, Phil, Bian, Boyang, Radican, Larry, Tunceli, Kaan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397849/
https://www.ncbi.nlm.nih.gov/pubmed/27003557
http://dx.doi.org/10.18553/jmcp.2016.22.3.272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397849/
https://www.ncbi.nlm.nih.gov/pubmed/27003557
http://dx.doi.org/10.18553/jmcp.2016.22.3.272

Ejemplares similares